Recombinant interferon-alpha 2 antibodies in chronic lymphocytic leukemia

Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer.

ESMO open·2025

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.

Bone marrow transplantation·2021

Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations.

JCO precision oncology·2019

The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults.

Bone marrow transplantation·2017

Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis.

Cancer treatment reviews·2017

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study.

Leukemia·2017

Rapid activation of the interferon-gamma signal transduction pathway by inhibitors of tyrosine phosphatases.

Journal of interferon research·1994

Interferon-stimulated response element and NF kappa B sites cooperate to regulate double-stranded RNA-induced transcription of the IP-10 gene.

Journal of interferon research·1994

Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia.

Journal of interferon research·1994

Modulation of peripheral leukocyte counts and bone marrow function in mice by oral administration of interleukin-2.

Journal of interferon research·1994

IDO mutants cross resistant to type I interferon retain p91-dependent gene induction.

Journal of interferon research·1994

Interferon-alpha 2 produced by normal human leukocytes is predominantly interferon-alpha 2b.

Journal of interferon research·1994

The locus coeruleus gateway hypothesis: Noradrenergic integrity as a candidate determinant of amyloid-β clearance efficiency in anti-amyloid immunotherapy for Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026

Pulmonary Light Chain Deposition Disease in a Patient With Chronic Lymphocytic Leukemia.

International journal of surgical pathology·2026

Tislelizumab-induced hyperamylasemia: Case report and safety analysis using the FAERS database.

International journal of clinical pharmacology and therapeutics·2026

Artifact-suppressed dual-modality OCT-fluorescence endoscopic imaging of colitis in murine models.

Biomedical optics express·2026

Adult-Onset Still's Disease as an Uncommon Cause of Fever of Unknown Origin.

Cureus·2026

Maternal Sjögren's Disease and Its Long Shadow: Adult-Onset Seronegative Lupus Nephritis Following Congenital Heart Block.

Cureus·2026

Related Experiment Videos

Recombinant interferon-alpha 2 antibodies in chronic lymphocytic leukemia

Related Concept Videos

Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer.

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.

Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations.

The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults.

Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis.

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study.

Rapid activation of the interferon-gamma signal transduction pathway by inhibitors of tyrosine phosphatases.

Interferon-stimulated response element and NF kappa B sites cooperate to regulate double-stranded RNA-induced transcription of the IP-10 gene.

Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia.

Modulation of peripheral leukocyte counts and bone marrow function in mice by oral administration of interleukin-2.

IDO mutants cross resistant to type I interferon retain p91-dependent gene induction.

Interferon-alpha 2 produced by normal human leukocytes is predominantly interferon-alpha 2b.

The locus coeruleus gateway hypothesis: Noradrenergic integrity as a candidate determinant of amyloid-β clearance efficiency in anti-amyloid immunotherapy for Alzheimer's disease.

Pulmonary Light Chain Deposition Disease in a Patient With Chronic Lymphocytic Leukemia.

Tislelizumab-induced hyperamylasemia: Case report and safety analysis using the FAERS database.

Artifact-suppressed dual-modality OCT-fluorescence endoscopic imaging of colitis in murine models.

Adult-Onset Still's Disease as an Uncommon Cause of Fever of Unknown Origin.

Maternal Sjögren's Disease and Its Long Shadow: Adult-Onset Seronegative Lupus Nephritis Following Congenital Heart Block.

Related Experiment Videos

Recombinant interferon-alpha 2 antibodies in chronic lymphocytic leukemia

Related Concept Videos

Related Articles